WallStreetZenWallStreetZen

NYSE: SCL
Stepan Co Stock Forecast, Predictions & Price Target

Buy SCL
OverviewForecast
EarningsDividendOwnership

Analyst price target for SCL

Based on 2 analysts offering 12 month price targets for Stepan Co.
Min Forecast
$133.00+23.89%
Avg Forecast
$139.00+29.48%
Max Forecast
$145.00+35.07%

Should I buy or sell SCL stock?

Based on 3 analysts offering ratings for Stepan Co.
Buy
Strong Buy
1 analysts 33.33%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is SCL forecast to generate an efficient return?
Company
N/A
Industry
37.51%
Market
28.93%

Forecast return on assets

Is SCL forecast to generate an efficient return on assets?
Company
N/A
Industry
9.76%

SCL earnings per share forecast

What is SCL's earnings per share in the next 2 years based on estimates from 4 analysts?
Avg 1 year Forecast
$6.75+2.27%
Avg 2 year Forecast
$7.28+10.3%
SCL's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

SCL revenue forecast

What is SCL's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$2.7B+1.7%
Avg 2 year Forecast
$2.7B+1.27%
Avg 3 year Forecast
$2.9B+8.37%
SCL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SCL earnings growth forecast

How is SCL forecast to perform vs Specialty Chemicals companies and vs the US market?
Company
5.77%
Industry
27.63%
Market
16.41%
SCL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
SCL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
SCL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

SCL revenue growth forecast

How is SCL forecast to perform vs Specialty Chemicals companies and vs the US market?
Company
1.82%
Industry
4.5%
Market
8.55%
SCL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SCL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SCL vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
SCL$107.35$139.00+29.48%Buy
IOSP$96.65N/AN/AHold
GCP$31.55$32.00+1.43%Hold
WDFC$184.59$146.50-20.63%Buy
GPRE$37.84$47.00+24.21%Buy
View Top Specialty Chemical Stocks

Stepan Co Stock Forecast FAQ

Is Stepan Co Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: SCL) stock is to Buy SCL stock.

Out of 3 analysts, 1 (33.33%) are recommending SCL as a Strong Buy, 0 (0%) are recommending SCL as a Buy, 2 (66.67%) are recommending SCL as a Hold, 0 (0%) are recommending SCL as a Sell, and 0 (0%) are recommending SCL as a Strong Sell.

If you're new to stock investing, here's how to buy Stepan Co stock.

What is SCL's earnings growth forecast for 2022-2023?

(NYSE: SCL) Stepan Co's forecast annual earnings growth rate of 5.77% is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 27.63%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.41%.

Stepan Co's earnings in 2022 is $150,850,000.On average, 4 Wall Street analysts forecast SCL's earnings for 2022 to be $150,558,305, with the lowest SCL earnings forecast at $137,621,443, and the highest SCL earnings forecast at $161,041,623.

In 2023, SCL is forecast to generate $162,379,920 in earnings, with the lowest earnings forecast at $148,996,959 and the highest earnings forecast at $167,956,153.

What is SCL's revenue growth forecast for 2022-2024?

(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 1.82% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.55%.

Stepan Co's revenue in 2022 is $2,639,624,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2022 to be $59,879,825,816, with the lowest SCL revenue forecast at $58,516,994,349, and the highest SCL revenue forecast at $60,589,122,718. On average, 3 Wall Street analysts forecast SCL's revenue for 2023 to be $59,625,549,569, with the lowest SCL revenue forecast at $56,007,689,274, and the highest SCL revenue forecast at $61,798,050,140.

In 2024, SCL is forecast to generate $63,805,494,200 in revenue, with the lowest revenue forecast at $63,805,494,200 and the highest revenue forecast at $63,805,494,200.

What is SCL's forecast return on assets (ROA) for 2022-2025?

(NYSE: SCL) forecast ROA is N/A, which is lower than the forecast US Specialty Chemicals industry average of 9.76%.

What is SCL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SCL price target, the average SCL price target is $139.00, with the highest SCL stock price forecast at $145.00 and the lowest SCL stock price forecast at $133.00.

On average, Wall Street analysts predict that Stepan Co's share price could reach $139.00 by Aug 4, 2023. The average Stepan Co stock price prediction forecasts a potential upside of 29.48% from the current SCL share price of $107.35.

What is SCL's Earnings Per Share (EPS) forecast for 2022-2023?

(NYSE: SCL) Stepan Co's current Earnings Per Share (EPS) is $6.60. On average, analysts forecast that SCL's EPS will be $6.75 for 2022, with the lowest EPS forecast at $6.17, and the highest EPS forecast at $7.22. In 2023, SCL's EPS is forecast to hit $7.28 (min: $6.68, max: $7.53).

What is SCL's forecast return on equity (ROE) for 2022-2025?

(NYSE: SCL) forecast ROE is N/A, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.